Suppr超能文献

潜在可切除胰腺导管腺癌隐匿性转移的预测因素

Predictors of occult metastases in potentially Resectable pancreatic ductal adenocarcinoma.

作者信息

Murakami Takeshi, Kimura Yasutoshi, Imamura Masafumi, Nagayama Minoru, Kato Toru, Kukita Kazuharu, Yoshida Makoto, Masaki Yoshiharu, Nakase Hiroshi, Takemasa Ichiro

机构信息

Department of Surgery, Surgical Oncology and Science, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-0061, Japan.

Department of Medical Oncology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-0061, Japan.

出版信息

Surg Open Sci. 2024 Jul 22;20:222-229. doi: 10.1016/j.sopen.2024.07.010. eCollection 2024 Aug.

Abstract

BACKGROUND

Patients with resectable (R) or borderline resectable (BR) pancreatic ductal adenocarcinoma (PDAC) sometimes show unexpected liver, peritoneal, and para-aortic lymph node metastases intraoperatively. Despite radical pancreatectomy, a nonnegligible number of patients relapse within 6 months after surgery. The aim of this study was to identify the preoperative predictors of occult metastases (OM), defined as intraoperative distant metastases or within 6 months after pancreatectomy.

MATERIALS AND METHODS

This study included patients with R and BR PDAC who underwent curative-intent pancreatectomy or staging laparoscopy between 2006 and 2021. Multivariate logistic regression and Cox hazard analyses were performed to identify the preoperative predictors of OM and to assess the impact of these factors on prognosis after pancreatectomy.

RESULTS

Of the 279 patients, OM was observed intraoperatively in 47 and postoperatively in 34. In the OM group, there were no differences in prognosis between patients who had intraoperative metastases and recurrence within 6 months (median survival time [MST], 18.1 vs. 12.9 months), and between patients who underwent pancreatectomy and those who did not (MST, 13.9 vs. 18.1 months). Preoperative tumor size ≥22 mm (odds ratio [OR], 2.03; 95 % confidence interval [CI], 1.16-3.53;  = 0.013) and preoperative CA19-9 level ≥ 118.8 U/mL (OR, 2.64; 95 % CI, 1.22-5.73;  = 0.014) were significant predictors of OM. Additionally, positive OM predictors were strong independent prognostic factors for overall survival after pancreatectomy (hazard ratio, 2.47; 95 % CI, 1.54-3.98;  < 0.001).

CONCLUSION

Multidisciplinary treatment strategies should be considered for patients with predictors of OM to avoid inappropriate surgical interventions.

摘要

背景

可切除(R)或临界可切除(BR)的胰腺导管腺癌(PDAC)患者有时在术中会出现意外的肝、腹膜和腹主动脉旁淋巴结转移。尽管进行了根治性胰腺切除术,但仍有相当数量的患者在术后6个月内复发。本研究的目的是确定隐匿性转移(OM)的术前预测因素,OM定义为术中远处转移或胰腺切除术后6个月内出现的转移。

材料与方法

本研究纳入了2006年至2021年间接受根治性胰腺切除术或分期腹腔镜检查的R和BR PDAC患者。进行多因素逻辑回归和Cox风险分析,以确定OM的术前预测因素,并评估这些因素对胰腺切除术后预后的影响。

结果

在279例患者中,47例术中观察到OM,34例术后观察到OM。在OM组中,术中转移和6个月内复发的患者之间(中位生存时间[MST],18.1个月对12.9个月),以及接受胰腺切除术和未接受胰腺切除术的患者之间(MST,13.9个月对18.1个月),预后无差异。术前肿瘤大小≥22 mm(比值比[OR],2.03;95%置信区间[CI],1.16 - 3.53;P = 0.013)和术前CA19 - 9水平≥118.8 U/mL(OR,2.64;95% CI,1.22 - 5.73;P = 0.014)是OM的显著预测因素。此外,OM阳性预测因素是胰腺切除术后总生存的强独立预后因素(风险比,2.47;95% CI,1.54 - 3.98;P < 0.001)。

结论

对于有OM预测因素的患者,应考虑多学科治疗策略,以避免不适当的手术干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ae7/11327574/e6f55b929cdd/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验